Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Almond

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Vaccine|December 27, 2016
The role of the vaccines industry in Mission Grand ConvergenceJeffrey Almond, Donata Medaglini
Lancet (London, England)|February 1, 2011
Dengue vaccine prospects: a step forwardBruno Guy, Jeffrey Almond, Jean Lang
British Medical Bulletin|August 15, 2002
Delivery technologies for human vaccinesPhilippe Moingeon, Charles de Taisne, Jeffrey Almond
Current Opinion in Microbiology|October 24, 2003
Therapeutic vaccines against infectious diseasesPhilippe Moingeon, Jeffrey Almond, Michel de Wilde
Vaccine|August 7, 2002
Accelerating the development and introduction of a dengue vaccine for poor children, 5-8 December 2001, Ho Chi Minh City, VietNamJeffrey Almond, John Clemens, Howard Engers, et al.
Microlife|July 8, 2021
Development of vaccines at the time of COVID-19Jeffrey Almond, Jörg Hacker, Colin Harwood, et al.
Plos One|June 25, 2015
CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent MannerKwang-Il Jeong, Peter A Piepenhagen, Michael Kishko, et al.
Plos One|October 17, 2012
Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital modelSimon Delagrave, Hector Hernandez, Changhong Zhou, et al.
Diabetologia|November 6, 2014
A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse modelsPär G Larsson, Tadepally Lakshmikanth, Olli H Laitinen, et al.
Vaccine|May 1, 2014
Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypesKirill Kalnin, Timothy Tibbitts, Yanhua Yan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Vaccine|December 27, 2016
The role of the vaccines industry in Mission Grand ConvergenceJeffrey Almond, Donata Medaglini
Lancet (London, England)|February 1, 2011
Dengue vaccine prospects: a step forwardBruno Guy, Jeffrey Almond, Jean Lang
British Medical Bulletin|August 15, 2002
Delivery technologies for human vaccinesPhilippe Moingeon, Charles de Taisne, Jeffrey Almond
Current Opinion in Microbiology|October 24, 2003
Therapeutic vaccines against infectious diseasesPhilippe Moingeon, Jeffrey Almond, Michel de Wilde
Vaccine|August 7, 2002
Accelerating the development and introduction of a dengue vaccine for poor children, 5-8 December 2001, Ho Chi Minh City, VietNamJeffrey Almond, John Clemens, Howard Engers, et al.
Microlife|July 8, 2021
Development of vaccines at the time of COVID-19Jeffrey Almond, Jörg Hacker, Colin Harwood, et al.
Plos One|June 25, 2015
CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent MannerKwang-Il Jeong, Peter A Piepenhagen, Michael Kishko, et al.
Plos One|October 17, 2012
Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital modelSimon Delagrave, Hector Hernandez, Changhong Zhou, et al.
Diabetologia|November 6, 2014
A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse modelsPär G Larsson, Tadepally Lakshmikanth, Olli H Laitinen, et al.
Vaccine|May 1, 2014
Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypesKirill Kalnin, Timothy Tibbitts, Yanhua Yan, et al.
Pageof 2